MedPath

To Compare Two Different Modes of Corneal Collagen Cross Linking for Strenghtening Cornea in Keratoconus

Not Applicable
Conditions
Health Condition 1: null- keratoconus and corneal ectatic conditions
Registration Number
CTRI/2015/06/005926
Lead Sponsor
ethradhama Superspeciality eye Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

•Worsening of uncorrected distance visual acuity (UDVA) or best corrected distance visual acuity (BDVA) of > 0.50 Snellen lines

•Increase of manifest spherical or cylindrical refractive error of > 0.50 Diopter

•Increase in steepest keratometry value (on Sim K or Manual) by >=1D

•Increase in mean K reading >= 1â??D

•Reduction of the thinnest point at corneal optical coherence tomography (OCT) pachymetry >=10â??μm

Exclusion Criteria

•Thin corneas ( Corneal pachymetry at thinnest point < 400um)

•Prior herpetic infection because it may result in viral reactivation

•Concurrent infection

•Severe corneal scarring or opacification

•History of poor epithelial wound healing

•Severe ocular surface disease ( moderate to severe dry eyes Schirmer test I < 10 mm)

•Autoimmune disorders

•Pregnant and nursing mother

•Previous intraocular and corneal surgery

•Glaucoma or IOP higher than 24mmHg

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the pulsed mode with the continuous mode of accelerated corneal collagen cross linking (KXL) in terms of efficacy and safety for keratoconus.Timepoint: Follow-up on day 1, ady 5, day 30 , 3 months and 6 months post-operatively.
Secondary Outcome Measures
NameTimeMethod
To assess the quality to vision and post-operative complications if any.Timepoint: Follow-up on day 1, ady 5, day 30 , 3 months and 6 months post-operatively.
© Copyright 2025. All Rights Reserved by MedPath